# A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults

> **NCT02201849** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 104 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Study Drug
- **DRUG:** Active Control
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02201849
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2019-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02201849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02201849, "A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02201849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*